Publications
" " "
X-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector." Hum Gene Ther 23, no. 6 (2012): 635-646.
"X-Linked Inhibitor of Apoptosis Protein (XIAP)-Mediated Attenuation of Apoptosis Using a Novel Cardiac Enhanced Adeno-Associated Viral Vector." CIRCULATION 122, no. 21 (2010).
"WNT3 is a biomarker capable of predicting the definitive endoderm differentiation potential of hESCs." Stem cell reports 1, no. 1 (2013): 46-52.
"Whole-cell-analysis of live cardiomyocytes using wide-field interferometric phase microscopy." Biomedical optics express 1, no. 2 (2010): 706-719.
"Whole cell imaging based on wide-field interferometric phase microscopy and its application to cardiomyocytes." Progress in Biomedical Optics and Imaging - Proceedings of SPIE 7904 (2011).
"Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles." Annals of biomedical engineering 42, no. 7 (2014): 1391-1405.
"Translating musculoskeletal bioengineering into tissue regeneration therapies." Science translational medicine 14, no. 666 (2022).
"Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming." PloS one 8, no. 5 (2013): e63577.
"Towards a functional tissue engineered cardiac muscle." Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings 1 (1999): 125-.
"Toward improved understanding of cardiac development and congenital heart disease: The advent of cardiac organoids." J Thorac Cardiovasc Surg 164, no. 6 (2022): 2013-2018.
"Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers." Toxicological sciences : an official journal of the Society of Toxicology 176, no. 1 (2020): 124-136.
"Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes." Biomaterials 34, no. 23 (2013): 5813-5820.
"Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs." Sci Rep 6 (2016).
"Tissue engineering of functional skeletal muscle: challenges and recent advances." IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society 27, no. 5 (2008): 109-113.
"Tissue engineering of functional cardiac muscle: Molecular, structural, and electrophysiological studies." American Journal of Physiology Heart and Circulatory Physiology 280, no. 1 49-1 (2001): H168-H178.
"Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies." American journal of physiology. Heart and circulatory physiology 280, no. 1 (2001): H168-H178.
"Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium." Science advances 10, no. 4 (2024).
"Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation." Annals of surgery 235, no. 2 (2002): 292-296.
"Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease." Commun Biol 4, no. 1 (2021).
"Three-dimensional environment promotes in vitro differentiation of cardiac myocytes." Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings 1 (1999): 128-.
"Three-dimensional cultures of cardiomyocytes for electrophysiological studies of cardiac muscle." Annals of Biomedical Engineering 28, no. SUPPL 1 (2000): S - 54.
"Tension Creates an Endoreplication Wavefront that Leads Regeneration of Epicardial Tissue." Dev Cell 42, no. 6 (2017): 600-615.e4.
"